Hello Tomorrow invites you to their event
About this event
Hello Tomorrow in collaboration with Orano Med will present their new innovation challenge
It will include:
Join us to meet the team and ask your questions!
The session will be recorded and shared with registered participants.
Tuesday November 8th, 5:30pm CET!
------------------
Early 2000s, AREVA (now Orano) sought to develop the use of materials derived from its core nuclear energy activities. Nuclear medicine and Targeted Alpha Therapy quickly appeared very promising. AREVA Med was created in 2009 (Renamed Orano Med in 2018) to develop new cancer therapies, leading to the world’s first clinical trials with ²¹²Pb performed between 2012 and 2014. Today, Orano Med has more than 80 employees in France and the USA.
Learn more now about the Challenge here
Start you application here
Contact marwan.aitomar@hello-tomorrow.org for any information regarding the Innovation Challenge
Hosted by
Building a collaborative ecosystem that leverages the power of emerging technologies to tackle world challenges has been Hello Tomorrow’s mission since 2011.
